Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/PHARMAESSENTIA-CORPORATIO-26902371/news/PharmaEssentia-Corp-Announces-Submission-of-New-Drug-Registration-of-BESREMi-Ropeginterferon-Alfa-43775827/?utm_source=whatsapp&utm_medium=social&utm_campaign=share